Axon Enterprise, Inc. (NASDAQ: AAXN)
Hagens Berman Sobol Shapiro LLP alerts investors in Axon Enterprise, Inc. (NASDAQ: AAXN) to the SEC’s review of the Company’s historical financial statements and the firm’s investigation into potential securities law violations.
If you purchased or otherwise acquired securities of Axon Enterprise between March 6, 2017 and October 20, 2017 and suffered losses contact AAXN@hbsslaw.com.
After the market closed on October 19, 2017, Axon Enterpise, Inc. announced the SEC issued a comment letter relating to its review of Axon’s Form 10-K for the year ended December 31, 2016 and Form 10-Q for the quarter ended March 31, 2017.
This news drove the price of Axon shares down as much as $1.58, or about 6.4%, during intraday trading on October 20, 2017.
“We’re focused on the possibility that material weaknesses in internal controls over financial reporting have led to improper revenue recognition or other violations of GAAP,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding Axon Enterprise should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email AAXN@hbsslaw.com.
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.